Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi SarcomaHenry Koon, Susan E. Krown, Ethel Cesarman et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2010Cited by 60
Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control designSusan E. Krown, Henry Koon, Barbara Fingleton et al.|Infectious Agents and Cancer|2010Cited by 0